Jason joins us from Amgen, where he spent nearly 20 years working as a regulatory strategist in multiple therapeutic areas (oncology therapeutics and supportive care, inflammation, and metabolic diseases) as well as leading Regulatory CMC teams for both synthetic and biologic products. Jason’s experience extends to all phases of the product lifecycle and he has worked with U.S., European, and many emerging market regulatory agencies. Prior to Amgen, he worked in regulatory consultancy, and as a project manager at GlaxoWellcome. Jason holds a BSc with Honors from the University of the West of England, UK, and a Diploma, in Regulatory Affairs from the University of Wales, Cardiff, UK.
Current role
May, 2021